Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Browse Lab Results > 2005-0007

Trial Summary

About CDAS Project, PI, Publications: Breast Cancer: Molecular Epidemiology in the PLCO EEMS Cohort - Hormones and Growth Factors

Datasets

Site: Breast

Inclusion Criteria:

  • In Genotype Population
  • With no other cancer diagnosis
  • T0 Serum Available
  • 1+ Serum Draw Post-Diagnosis (Biochemical Population)
  • Not Current HRT User (HRT Population)
  • Definitely Post-Menopausal
  • 3 Vials Perfect T0 Serum Available (ADD2 population)

Matching Factors:

  • Age at Randomization (5 year intervals)
  • Fiscal Year of Randomization (2 year intervals)

Match Ratio: 1 to 1

Match Technique: Frequency matching only non-cases as controls.

Analytes:

  • 1,25-dihydroxyvitamin D3
  • 16-Epiestriol
  • 16-Ketoestradiol
  • 16Alpha-Hydroxyestrone
  • 17-Epiestriol
  • 2-Hydroxyestradiol
  • 2-Hydroxyestrone
  • 2-Hydroxyestrone-3-Methyl Ether
  • 2-Methoxyestradiol
  • 2-Methoxyestrone
  • 25-Hydroxyvitamin D
  • 4-Hydroxyestrone
  • 4-Methoxyestradiol
  • 4-Methoxyestrone
  • Estradiol
  • Estriol
  • Estrone
  • Insulin-like Growth Factor 1
  • Insulin-like Growth Factor Binding Protein 3
  • Prolactin

Number of Cases: 1001

Number of Controls: 1002